A multicentre phase II study of hypofractionated stereostatic boost in intermediate risk prostate carcinoma: a 5-year analysis of the CKNO-PRO trial.

Fiche publication


Date publication

octobre 2019

Journal

International journal of radiation oncology, biology, physics

Auteurs

Membres identifiés du Cancéropôle Est :
Pr PEIFFERT Didier


Tous les auteurs :
Pasquier D, Peiffert D, Nickers P, Maingon P, Pommier P, Lacornerie T, Martinage G, Tresch E, Lartigau E

Résumé

The aim of this analysis was to assess the 5-year tolerance and survival in patients undergoing hypofractionated stereotactic boost after external beam radiotherapy (EBRT) for intermediate-risk prostate cancer.

Référence

Int. J. Radiat. Oncol. Biol. Phys.. 2019 Oct 8;: